These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 13044)

  • 1. Apomorphine: chemistry, pharmacology, biochemistry.
    Colpaert FC; Van Bever WF; Leysen JE
    Int Rev Neurobiol; 1976; 19():225-68. PubMed ID: 13044
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology and neurochemistry of apomorphine.
    Di Chiara G; Gessa GL
    Adv Pharmacol Chemother; 1978; 15():87-160. PubMed ID: 358806
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible anomalous behaviour of apomorphine in relation to other dopamine receptor agonists.
    Feenstra MG; Goedemoed JH; Rollema H; Horn AS
    J Pharm Pharmacol; 1983 Jul; 35(7):471-3. PubMed ID: 6136595
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.
    Fuxe K; Fredholm BB; Agnati LF; Ogren SO; Everitt BJ; Jonsson G; Gustafsson JA
    Pharmacology; 1978; 16 Suppl 1():99-134. PubMed ID: 643908
    [No Abstract]   [Full Text] [Related]  

  • 5. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN; Jenner P; Huizing G; Marsden CD; Miller R
    Neuropharmacology; 1977 May; 16(5):333-42. PubMed ID: 559256
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in dopamine receptor sensitivity by chronic ethanol treatment.
    Hoffman PL; Tabakoff B
    Nature; 1977 Aug; 268(5620):551-3. PubMed ID: 887173
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple receptors for dopamine.
    Kebabian JW; Calne DB
    Nature; 1979 Jan; 277(5692):93-6. PubMed ID: 215920
    [No Abstract]   [Full Text] [Related]  

  • 8. Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphine.
    Neumeyer JL; Arana GW; Ram VJ; Kula NS; Baldessarini RJ
    J Med Chem; 1982 Aug; 25(8):990-2. PubMed ID: 7120288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology and biochemistry of haloperidol.
    Niemegeers CJ; Laduron PM
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):3-8. PubMed ID: 14331
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide.
    Crider AM; Hemdi TF; Hassan MN; Fahn S
    J Pharm Sci; 1984 Nov; 73(11):1585-7. PubMed ID: 6549185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion.
    Lal S; Nair NP; Cervantes P; Pulman J; Guyda H
    Acta Psychiatr Scand; 1979 Feb; 59(2):173-9. PubMed ID: 420037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of apomorphine hydrochloride administration on serum concentrations of prolactin and growth hormone in cattle.
    Gorewit RC
    Experientia; 1981 Feb; 37(2):204-6. PubMed ID: 7238762
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
    Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agents acting on central dopamine receptors.
    Kumar N; Jain PC
    Prog Drug Res; 1977; 21():409-65. PubMed ID: 22892
    [No Abstract]   [Full Text] [Related]  

  • 15. Guanine nucleotides distinguish between two dopamine receptors.
    Creese I; Usdin T; Snyder SH
    Nature; 1979 Apr; 278(5704):577-8. PubMed ID: 431724
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology and biochemistry of bromperidol.
    Niemegeers CJ; Laduron PM; Janssen PA
    Acta Psychiatr Belg; 1978; 78(1):37-50. PubMed ID: 645406
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct evidence for presynaptic and postsynaptic dopamine receptors in brain.
    Nagy JI; Lee T; Seeman P; Fibiger HC
    Nature; 1978 Jul; 274(5668):278-81. PubMed ID: 683308
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of dopamine agonists in tardive dyskinesia.
    Smith RC; Tamminga CA; Haraszti J; Pandey GN; Davis JM
    Am J Psychiatry; 1977 Jul; 134(7):763-8. PubMed ID: 869053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.